Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,280 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Piracetam: novelty in a unique mode of action.
Müller WE, Eckert GP, Eckert A. Müller WE, et al. Pharmacopsychiatry. 1999 Mar;32 Suppl 1:2-9. doi: 10.1055/s-2007-979230. Pharmacopsychiatry. 1999. PMID: 10338102 Review.
Chronic treatment with piracetam elevates muscarinic cholinergic receptor density in the frontal cortex of aged mice.
Pilch H, Müller WE. Pilch H, et al. Among authors: muller we. Pharmacopsychiatry. 1988 Nov;21(6):324-5. doi: 10.1055/s-2007-1016995. Pharmacopsychiatry. 1988. PMID: 3244761 No abstract available.
Hyperforin represents the neurotransmitter reuptake inhibiting constituent of hypericum extract.
Müller WE, Singer A, Wonnemann M, Hafner U, Rolli M, Schäfer C. Müller WE, et al. Pharmacopsychiatry. 1998 Jun;31 Suppl 1:16-21. doi: 10.1055/s-2007-979341. Pharmacopsychiatry. 1998. PMID: 9684943
Ginkgo biloba extract (EGb 761) independently improves changes in passive avoidance learning and brain membrane fluidity in the aging mouse.
Stoll S, Scheuer K, Pohl O, Müller WE. Stoll S, et al. Among authors: muller we. Pharmacopsychiatry. 1996 Jul;29(4):144-9. doi: 10.1055/s-2007-979561. Pharmacopsychiatry. 1996. PMID: 8858713
To test if there is a link between these two actions we assessed the effects of EGb 761 on passive avoidance learning and on neuronal membrane fluidity in vivo in young (three-month-old), middle-aged (12-month-old) and aged (22 to 24-month-old) female NMRI mice. ...
To test if there is a link between these two actions we assessed the effects of EGb 761 on passive avoidance learning and on neuronal …
Noncompetitive NMDA receptor antagonists with fast open-channel blocking kinetics and strong voltage-dependency as potential therapeutic agents for Alzheimer's dementia.
Müller WE, Mutschler E, Riederer P. Müller WE, et al. Pharmacopsychiatry. 1995 Jul;28(4):113-24. doi: 10.1055/s-2007-979603. Pharmacopsychiatry. 1995. PMID: 7491365 Review.
Biochemical models for cognition enhancers.
Costall B, Barnes JM, Hamon M, Müller WE, Briley M. Costall B, et al. Among authors: muller we. Pharmacopsychiatry. 1990 Feb;23 Suppl 2:85-8; discussion 89. doi: 10.1055/s-2007-1014540. Pharmacopsychiatry. 1990. PMID: 2186420 Review.
The complexity of the dopaminergic synapses and their modulation by antipsychotics.
Leuner K, Müller WE. Leuner K, et al. Among authors: muller we. Pharmacopsychiatry. 2006 Feb;39 Suppl 1:S15-20. doi: 10.1055/s-2006-931484. Pharmacopsychiatry. 2006. PMID: 16508891
Accordingly, in this review we focus on the neuropharmacology of the dopaminergic system in our brain with special emphasis on the dopaminergic synapse....
Accordingly, in this review we focus on the neuropharmacology of the dopaminergic system in our brain with special emphasis on the do …
Treatment of comorbid anxiety and depression with escitalopram: results of a post-marketing surveillance study.
Laux G, Friede M, Müller WE. Laux G, et al. Among authors: muller we. Pharmacopsychiatry. 2013 Jan;46(1):16-22. doi: 10.1055/s-0032-1311627. Epub 2012 May 30. Pharmacopsychiatry. 2013. PMID: 22648305
Direct and indirect effects of alprazolam and imipramine on alpha 1- and alpha 2-adrenoceptors in mouse forebrain.
Rick-Brand S, Müller WE. Rick-Brand S, et al. Among authors: muller we. Pharmacopsychiatry. 1988 Nov;21(6):319-20. doi: 10.1055/s-2007-1016993. Pharmacopsychiatry. 1988. PMID: 2854275 No abstract available.
Editorial.
Müller WE, Chatterjee SS. Müller WE, et al. Pharmacopsychiatry. 2003 Jun;36 Suppl 1:S1. Pharmacopsychiatry. 2003. PMID: 14503561 No abstract available.
1,280 results
Jump to page
Feedback